Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
Coll freshman Bad
|
New words:
aberrant, absolute, abundant, Additionally, assumption, automatically, binding, Bio, cell, central, chemotherapy, CNS, death, Denmark, detect, detected, Eastern, economy, error, excellent, experimental, experimentation, fraud, GLP, GmbH, Good, growth, horse, Immunity, immunotherapy, inflation, inflationary, inside, interval, KemPharm, maintenance, matter, met, nutritional, parallel, past, plasma, protein, pursue, put, question, range, rare, run, sarcoma, showing, signaling, Society, specialty, structure, transport, trojan, uncommon, vascular, wholly
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view